Lumen Bioscience

Lumen Bioscience

  • Founded: 2017
  • Location: Seattle, WA
  • Employee range: 50 - 200
  • Clinical stage: Clin2
  • Therapy area: Traveler’s diarrhea
  • Drug types: INF, GI, CVV
  • Lead product: Undisclosed
  • Product link:
  • Funding: $16M B Aug 2020; $13M Dec 2017

job board

Short description:


Drug notes:

Undisclosed Clin1 C. difficile colitis; undisclosed Clin0 COVID-19; undisclosed Clin0 IBD; undisclosed Clin0 cardiometabolic disease

Long description:

Lumen Bioscience is developing new drugs for highly prevalent diseases. Many highly prevalent diseases have proven impossible to treat with traditional drug-making tools, despite much research. Lumen is using their unique technology to address these issues. Using their patented technology, Lumen is developing biologic drugs faster and with lower cost and risk than traditional methods. This involves the innovative use of spirulina cells to generate the therapeutic protein - these cells require only water, salt, CO2 and light making production cheap and rapidly scalable. As a platform company, Lumen can create their own portfolio of commercially viable therapies.


Lumen Bioscience
QC Specialist, Biochemical Assays
Seattle, WA|8 days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy